Epstein Secrets

Today <https://www.usatoday.com/story/news/nation/2020/09/22/covid-trump-praises-administration-us- hits-200-k-coronavirus-deaths/5851354002/> (9/22, Rodriguez, 10.31M) reports that in March, Trump "said keeping the death toll between 100,000 to 200,000 people would have indicated that his administration ha

izer-s-covid-vaccine-trial-plan-may-beat- rivals-to-early-look?smd=premium> (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first look

taken by the Administration to counter the virus. Trump said, "It's a horrible thing. China let this happen. Just remember that." USA Today (9/22, Rodriguez, 10.31M) reports that in March, Trump "said keeping the death toll between 100,000 to 200,000 people would have indicated that his administration ha

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

Edward B. Rock Christopher Rodrigues Carlos Rodriguez-Pastor James E. Rogers Jim Rogers John F. W. R

d Chief Executive Officer Desjardins Group The Boston Consulting Group Lloyd's Yale University DareDevil Strategies Amobee Publicis Groupe SA Pfizer Inc. Accel Partners Center for China in the World Economy (CCWE) The George Institute for Global Health Balderton Capital thesystemis Bloomberg Ne

taken by the Administration to counter the virus. Trump said, "It's a horrible thing. China let this happen. Just remember that." USA Today (9/22, Rodriguez, 10.31M) reports that in March, Trump "said keeping the death toll between 100,000 to 200,000 people would have indicated that his administration ha

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo